About HealthMap
HealthMap is a company based in Delhi (India) founded in 2015. HealthMap has raised $20.55 million across 1 funding round from investors including Morgan Stanley. The company has 414 employees as of April 04, 2024. HealthMap has completed 1 acquisition, including MEDCIS Pathlabs India. HealthMap offers products and services including CT Scan, MRI, Ultrasound, Blood Tests, and X-Ray. HealthMap operates in a competitive market with competitors including Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics and Igenetic, among others.
- Headquarter Delhi, India
- Employees 414 as on 04 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Healthmap Diagnostics Private Limited
- Date of Incorporation 06 Apr, 2015
- Jurisdiction Bangaluru, Karnataka, India
-
Annual Revenue
$10.19 M (USD)9.07as on Mar 31, 2023
-
Net Profit
$340.03 K (USD)800.52as on Mar 31, 2023
-
EBITDA
$2.24 M (USD)76.31as on Mar 31, 2023
-
Total Equity Funding
$20.55 M (USD)
in 1 rounds
-
Latest Funding Round
$20.55 M (USD), Series B
May 15, 2019
- Investors
-
Employee Count
414
as on Apr 04, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HealthMap
HealthMap offers a comprehensive portfolio of products and services, including CT Scan, MRI, Ultrasound, Blood Tests, and X-Ray.
Diagnostic service for detailed internal body scans.
Advanced imaging for soft tissue and organ diagnostics.
Non-invasive scan for monitoring internal structures.
Routine and specialized tests for health analysis.
Radiographic imaging for bone and tissue examination.
People of HealthMap
Unlock access to complete
Center Team
1 people
Leadership Team
1 people
Cluster Team
1 people
Operations Team
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of HealthMap
HealthMap has successfully raised a total of $20.55M through 1 strategic funding round. The most recent funding activity was a Series B round of $20.55 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $20.6M
-
First Round
First Round
(15 May 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series B - HealthMap | Valuation | Morgan Stanley |
|
Investors in HealthMap
HealthMap has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Morgan Stanley.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wealth management, investment advisory, and financial services are provided.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HealthMap
HealthMap has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MEDCIS Pathlabs India.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Standalone clinical laboratory
|
2010 |
Financial Statements - HealthMap
Healthmap Comparisons
Competitors of HealthMap
HealthMap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics and Igenetic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic testing centers for pathology and health screenings are operated.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are offered via a chain of centers.
|
|
| domain | founded_year | HQ Location |
Pathology, molecular diagnostics, and imaging services are provided.
|
|
| domain | founded_year | HQ Location |
Chain of radiology & pathology laboratory centers
|
|
| domain | founded_year | HQ Location |
Provider molecular diagnostic solutions and services
|
Frequently Asked Questions about HealthMap
HealthMap was founded in 2015 and raised its 1st funding round 4 years after it was founded.
HealthMap is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Niraj Arora is the current CEO of HealthMap.
HealthMap is a funded company, having raised a total of $20.55M across 1 funding round to date. The company's 1st funding round was a Series B of $20.55M, raised on May 15, 2019.
As of Apr 04, 2024, the latest employee count at HealthMap is 414.
Annual revenue of HealthMap is $10.19M as on Mar 31, 2023.
HealthMap was established in 2015 in Delhi, India, within the healthcare diagnostics sector. A network of radiology labs is maintained across the region, focusing on imaging and diagnostic procedures. Services encompass X-rays, ultrasounds, and other radiological tests for medical evaluation. Operations are centered in India, with leadership provided by CEO Niraj Arora. The company supports clinical diagnostics for healthcare providers and patients.
HealthMap's top competitors include Thyrocare, Krsnaa Diagnostics and Suraksha Diagnostics.
HealthMap offers CT Scan, MRI, Ultrasound, Blood Tests, and X-Ray.
HealthMap has made 1 acquisition, including MEDCIS Pathlabs India.
HealthMap has 1 investor. Key investors include Morgan Stanley.
The valuation of HealthMap is $32.38M as of May 2019.